The Immunex Alumni: Where Are They Now?

1/3/11Follow @xconomy

(Page 11 of 11)

Bill Waye, senior database administrator, Amgen

Tim Westhoff, records manager, Sharebuilder

Cathi White, owner, ZLC & Associates

James Whitmore, vice president of biometrics, Dendreon

Mike Widmer, chairman of the board, Genmab

Christopher Wight, counsel at Brinks Hofer Gilson & Lione

Janis Wignall, owner, Wignall Consultant

Steven Wiley, founder and president, Imdaptive

Doug Williams, executive vice president of R&D, Biogen Idec [Updated:10:30 pm, 1/5/11]

Anita Williamson, contract recruiter

Robb Wolfe, information technology professional [Added: 4:40 pm, 1/4/11]

Sharon Wong-Madden, project manager, malaria program, Seattle Biomedical Research Institute

Mei-Ling Woo, agent/owner, State Farm Insurance

Zhengbin (Bing) Yao, senior vice president of respiratory, inflammation, autoimmunity, MedImmune [Added: 9:35 pm, 1/4/11]

Che-Hung Yeh, head of U.S. IMP quality operations, Roche/Genentech

Vanessa Pham Yi, manager, document administration, Quorum Review IRB

Adel Youakim, independent arts/crafts professional

Scott Young, supervisor, site engineering, Bayer Healthcare

Beth Ziemba, director of global safety surveillance, ZymoGenetics

Ed Zimney, safety operations physician, Genentech

Travis Zundel, executive account manager, Lifespan Biosciences

Craig Zupke, principal scientist, Amgen

Single Page Currently on Page: 1 2 3 4 5 6 7 8 9 10 11 previous page

By posting a comment, you agree to our terms and conditions.

  • Ajamete Kaykas

    Here are a few more that were forgotten;

    Jurgen Mulberg, Scientist Novartis Vaccine Research

    Pam Smolak, Scientist VLST

    Tom Cox, Scientist Novo Nordisk

    Ajamete Kaykas, Director Allen Institute for Brain Science

  • http://www.xconomy.com/author/ltimmerman/ Luke Timmerman

    Thanks Ajamete. I’ve added those people to the list above, and have added the most recent titles I see. I don’t see Mullberg’s new title with Novartis on LinkedIn, and based on her LinkedIn profile, Pam Smolak looks to be no longer with VLST.

    Like I said above in the story, if anyone wants to chime in with more updated titles, please let me know and I’ll make the change.

  • http://www.key2yourhome.net Stacey Lange

    As previous Immunex employee, I hold fond memories and just read an article about my dear old boss, Doug Williams who just accepted a new position as Executive V.P. of Biogen Idec
    http://www.boston.com/business/ticker/2011/01/biogen_idec_fil.html

  • Diane Kolb

    Luke, thanks for the great articles! I too read about Doug Williams and am happy to hear he’s heading back to R&D. So many talents came together under one roof at Immunex. To date, I continue to say that I have had a great career in my chosen path with many wonderful people…but so far, none has come close to the Immunex family.

  • Stephen Cole

    Thanks for this wonderful summary of our Immunex colleagues’ post-Imnx lives. Wonderful.

    Immunex was the start of my career in IT. After completing my MBA post-Amgen acquisition, I have managed in a series of IT organizations, inlcuding EMC, SGI, Commvault and now Symantec.

    I will forever be indebted to Immunex for the opportunity, the environment and the wonderful professionals that I met there.

  • http://www.xconomy.com/author/ltimmerman/ Luke Timmerman

    Stephen—thanks for the comment. I can’t help but wonder what you think it was about the culture that made Immunex so special, and how it’s different from many biotech workplaces of today. I’d love to hear from other Immunoids on that one too.

  • http://balboabioconsulting.com Gerald Kolaja

    I’m an ex-Immunoid. I’m consulting in pathology in San Diego. Baloa BioConsulting, LLC

  • Suzen

    Hi Luke.
    I was with Immunex in Bothell before the “Baby Poster” was released. I did stay with Amgen when we got bought, and moved to the Helix site on the waterfront. Many years have gone by and I have found myself in Denderon with other great collegues. I am the Corp. Facilities Maintenace Planner/Scheduler. Keith LaChappelle is here too. After he left when the “Baby Poster” came out, he struck out on his own and developed the http://www.chimpsanctuarynw.org. He has since come back into the BioTech world and is now my boss as the Corp. Facilities Manager here in Seattle. Small world.
    Hey Immuniods, wanna hook up for a meet up @ Maggies? It’s been so long! I’m also on LinkIN, find me! Happy New Year!
    Cheers,
    ~S~

  • Cathy McSharry

    I worked at Immunex from 1996 to 2002 and loved every minute of it. There will never be another Immunex. It was challenging yet rewarding. We were a family who worked together to accomplish the task at hand. I truly loved working at Immunex and miss it greatly. I agree with Diane, so many talents came together under one roof at Immunex.

  • http://www.supernapharma.com Tom D’Orazio

    Worked at Immunex from ’91-’94. Truly a dynamic environment composed of a work force with a collectively inspiring attitude. I am honored to have had the opportunity to experience it.

  • breana

    My mom was an immunoid, and she still works for Amgen. I’m doing a project for school on both companies, but I can’t find how many employees they had at any given time. Would somebody please tell me how many immunoids there were by 1982? Thank you very much.
    sincerely, Breana

  • http://pla.ce.bo.free.fr Jean-Philippe GERARD

    From august to october of 1982, I spent 3 months there as a research consultant, in part because of my frienship w/ Jacques Bertoglio (an INSERM scientist : french équivalenbt of NIH) who worked in Immunex a couple of years. It was the very beginning of Immunex, then localized on one floor of 51, University. My best souvenir ? The TGIF ! Thank’s God It’s Friday.
    Chris and Steven were very kind to me, but I couldn’t accept their proposal because of a national commitment (Service National). Dommage ! What a shame.
    Where are they, and Chris, and Steven, and Larry (Lachman), and etc. I just found Diane Mochizuki on LinkedIn.

    jpg

    Post-Scriptum : I found the mistake everybody made w/ IL-2. In fact, it’s very simple to make it works. We got a lysis syndrom w/ a multimetastaic lung carcinoma just adding 2 very spécific oligo-elements. Mysterious enough, isn’t it ?